Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Halobetasol Propionate Foam in Plaque Psoriasis
NCT02742441Phase 3Completed
- Start
- Jun 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Halobetasol propionate 0.05% lotion in plaque psoriasis. Started Jun 2016; status: completed.
02
Drugs
Halobetasol propionate 0.05% lotion
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT02742441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02742441.